Effect of Xuezhikang Therapy on Expression of Pulmonary Hypertension Related miR-638 in Patients With Low HDL-C Levels

• Κύριοι συγγραφείς: Ruihua Cao (Συγγραφέας), Tao Sun (Συγγραφέας), Ruyi Xu (Συγγραφέας), Jin Zheng (Συγγραφέας), Hao Wang (Συγγραφέας), Xiaona Wang (Συγγραφέας), Yongyi Bai (Συγγραφέας), Ping Ye (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Objective: Low plasma level of high-density lipoprotein cholesterol (HDL-C) associated with poor outcomes in several cardiovascular diseases, including pulmonary arterial hypertension (PAH). Regulation of miR-638 have been proved to be associated with PAH. The aim of this study was to evaluate the e...